Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,077 across all filing types
Latest filing 2025-08-15 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Alpha Group International plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealing disclosures of a person with interests in relevant securities representing 1% or more of a company involved in a takeover (Alpha Group International PLC). This type of disclosure is a specific regulatory requirement for market surveillance and does not fit into categories like M&A activity (which would be the announcement of the deal itself) or major shareholding notifications (which are typically TR-1 filings). Therefore, it is classified as a Regulatory Filing (RNS).
2025-08-15 English
Form 8.3 - American Axle & Manufacturing Holdings
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the public opening position and dealing disclosure by a person with interests in relevant securities representing 1% or more of an offeror or offeree. This is a specific regulatory requirement for transparency during M&A activity, and it does not fit into the other categories like M&A (TAR) or Shareholding Notification (MRQ) as perfectly as it fits the general regulatory filing category for these specific disclosure forms.
2025-08-15 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the opening position and dealings in the securities of 'Mural Oncology PLC' by 'Citadel Group'. This type of document is a mandatory disclosure of major shareholding interests and derivative positions during a takeover or merger process. It does not fit into the 'M&A Activity' (TAR) category as that is typically for company-level announcements, nor is it a 'Major Shareholding Notification' (MRQ) in the traditional sense of a simple threshold crossing; it is a specific regulatory disclosure form (Form 8.3) used in Irish takeover contexts. Therefore, it is best classified as a Regulatory Filing (RNS).
2025-08-15 English
Form 8.3 - Dowlais Group Plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of Dowlais Group PLC. Since this is a specific regulatory disclosure regarding shareholdings and market activity related to a takeover, it falls under the 'Major Shareholding Notification' category, which covers notifications of significant share ownership levels and related disclosures.
2025-08-15 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act for persons with interests in relevant securities representing 1% or more during a takeover or merger situation. It details shareholdings, dealings, and derivative positions. Since it does not fit into specific categories like 'Director's Dealing' (which is for company insiders) or 'Major Shareholding Notification' (which is for threshold crossings), and it is a formal regulatory disclosure regarding takeover-related activity, it is best classified as a Regulatory Filing (RNS).
2025-08-14 English
Form 8.3 - American Axle & Manufacturing Holdings
Regulatory Filings Classification · 100% confidence The document is a 'FORM 8.3' filing, which is a standard regulatory disclosure required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings (purchases and sales) in the common stock of American Axle & Manufacturing Holdings Inc. This type of disclosure is a specific regulatory requirement for transparency during M&A activity and does not fit into the other categories like M&A announcements (TAR) or director dealings (DIRS). Therefore, it is classified as a Regulatory Filing (RNS).
2025-08-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.